Article

Barkly Rare Earths (ASX: BAK) made a strong debut on the ASX, surging nearly 50% to 29.5c after raising $8 million for its Barkly project, with its IPO priced at 20c and oversubscribed due to rare earth supply chain concerns. Additionally, several companies reported progress, including AuMEGA Metals Ltd's exploration advancements in Canada and Recce Pharmaceuticals Ltd's advancements in its Phase 3 trial in Indonesia. Other notable updates included high-grade PGE3 results from Terra Metals Ltd and positive clinical results from Imugene Ltd's Phase 1b trial.